Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06690099 · ClinicalTrials.gov registry record
Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women
A clinical trial of Pregnancy and Rhesus D Genotype, sponsored by Devyser.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT06690099 is a study of Pregnancy and Rhesus D Genotype that is actively recruiting participants, run by Devyser. The registered enrollment target is 500 participants, below the 870-participant average among 191 other Pregnancy trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06690099, a study of Pregnancy and Rhesus D Genotype, is actively recruiting participants, sponsored by Devyser.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to collect blood samples and data from pregnant women who are Rh negative. The blood will be used for the future research and the development of non-invasive prenatal tests to identify Rh blood type status of the baby during pregnancy.
Conditions Studied
Study Locations (1)
Louisiana
- Ochsner Health - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-04-07 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06690099
The ClinicalTrials.gov registry entry for NCT06690099 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 870-participant average among 191 other Pregnancy trials with a reported enrollment target (43% lower). The listed sponsor is Devyser, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 0 interventions.
NCT06690099 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT06690099 about?
NCT06690099 is a clinical study titled "Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women". The purpose of this research is to collect blood samples and data from pregnant women who are Rh negative. The blood will be used for the future research and the development of non-invasive prenatal tests to identify Rh blood type status of the baby during pregnancy.
What is the current status of trial NCT06690099?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2025-04-07. Estimated completion is 2026-12.
What conditions does trial NCT06690099 study?
This clinical trial studies the following conditions: Pregnancy, Rhesus D Genotype.
Who is sponsoring clinical trial NCT06690099?
This trial is sponsored by Devyser, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06690099 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.